Treatment for glioblastoma (GBM)
This site is intended for US healthcare professionals only.


In this section, you'll find a variety of resources to help you better understand Optune, share this novel treatment with your patients who have newly diagnosed or recurrent glioblastoma (GBM), and start prescribing Optune.

Long-term quality survival brochure

Long-term Quality Survival brochure

Learn about Optune + TMZ for patients with newly diagnosed GBM.

View this PDF
Peer-reviewed publications

Peer-reviewed publications

Review various publications about Optune

See publications
Video library

Video library

Materials to help you become more familiar with Optune

Watch videos
Calendar of events

Calendar of events

Optune open houses and events focused on brain cancer

See upcoming events

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).